A cross border collaboration of researchers across two health jurisdictions, AllCaN is being described as a"game changer" for low survival cancer research on the island of Ireland.
The initial grant of one million euros will allow AllCaN to focus on research into oesophageal cancer to improve early detection and outcomes for patients with, or at risk of, developing the disease.In the Republic of Ireland there is a five-year survival rate of 24%.At the launch of AllCaN in Queen's University Belfast, Breakthrough Cancer Research CEO Orla Dolan said the collaboration"is a game changer for low survival cancer research on the island of Ireland.
"Research works and over the last 50 years, we have seen huge progress delivered in overall survival. Today we have over 200,000 cancer survivors in the Republic of Ireland but unfortunately, less than 1% of them have survived an oesophageal Cancer diagnosis. Research is not a luxury, it is a necessity", she said.
Researchers say the identification of, and improved treatments for people with Oesophageal Cancer and Barrett's oesophagus , could significantly control the progression of the disease and improve survival rates.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IrishTimesBiz - 🏆 6. / 77 Read more »
Source: thejournal_ie - 🏆 32. / 50 Read more »